Reviewing Inspire Medical Systems (NYSE:INSP) & Microbot Medical (NASDAQ:MBOT)

Inspire Medical Systems (NYSE:INSPGet Free Report) and Microbot Medical (NASDAQ:MBOTGet Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Profitability

This table compares Inspire Medical Systems and Microbot Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Inspire Medical Systems 4.37% 5.30% 4.58%
Microbot Medical N/A -218.30% -158.17%

Institutional & Insider Ownership

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 10.5% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility and Risk

Inspire Medical Systems has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Inspire Medical Systems and Microbot Medical, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems 0 3 9 0 2.75
Microbot Medical 0 0 1 0 3.00

Inspire Medical Systems currently has a consensus price target of $233.58, suggesting a potential upside of 26.50%. Microbot Medical has a consensus price target of $7.00, suggesting a potential upside of 493.22%. Given Microbot Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Inspire Medical Systems.

Valuation & Earnings

This table compares Inspire Medical Systems and Microbot Medical”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inspire Medical Systems $624.80 million 8.86 -$21.15 million $1.07 172.57
Microbot Medical N/A N/A -$10.74 million ($0.80) -1.48

Microbot Medical has lower revenue, but higher earnings than Inspire Medical Systems. Microbot Medical is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Summary

Inspire Medical Systems beats Microbot Medical on 8 of the 13 factors compared between the two stocks.

About Inspire Medical Systems

(Get Free Report)

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

About Microbot Medical

(Get Free Report)

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.